TTIPF (Thiogenesis Therapeutics) Preferred Dividends: $0.00 Mil (TTM As of Mar. 2026)

What is Thiogenesis Therapeutics Preferred Dividends?

Thiogenesis Therapeutics TTIPF -6.67% 12 Preferred Dividends is $0.00 Mil as of Mar. 2026. GuruFocus rates TTIPF with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Thiogenesis Therapeutics's preferred dividends for the three months ended in Mar. 2026 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Thiogenesis Therapeutics (OTCPK:TTIPF) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thiogenesis Therapeutics Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Thiogenesis Therapeutics's Preferred Dividends can be seen below:

Thiogenesis Therapeutics Preferred Dividends Chart

Thiogenesis Therapeutics Annual Data

Trend

Dec19

Dec20

Feb21

Feb22

Dec23

Dec24

Dec25

Preferred Dividends

Get a 7-Day Free Trial

0.00

Thiogenesis Therapeutics Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Preferred Dividends	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

12GF Score

Thiogenesis Therapeutics Corp TTIPF

Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Thiogenesis Therapeutics Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →

What does a Preferred Dividends of $0.00 Mil mean?

Thiogenesis Therapeutics (TTIPF) has a Preferred Dividends of $0.00 Mil as of Mar. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Thiogenesis Therapeutics and its competitors.

Is Thiogenesis Therapeutics' Preferred Dividends too high?

Thiogenesis Therapeutics' current Preferred Dividends is $0.00 Mil. Overall, Thiogenesis Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Thiogenesis Therapeutics' Preferred Dividends compare to VRTX and REGN?

Thiogenesis Therapeutics' Preferred Dividends of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Preferred Dividends for a Biotechnology company?

A good Preferred Dividends depends on the Biotechnology industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Preferred Dividends mean?

A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Thiogenesis Therapeutics and its competitors. Thiogenesis Therapeutics's current Preferred Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Thiogenesis Therapeutics stock overvalued right now?

Thiogenesis Therapeutics (TTIPF) has a current Preferred Dividends of $0.00 Mil. The current Preferred Dividends is $0.00 Mil. Thiogenesis Therapeutics' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Preferred Dividends calculated?

Preferred Dividends is calculated from a company's financial statements. For Thiogenesis Therapeutics (TTIPF), the current Preferred Dividends is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thiogenesis Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies TSXV:GSD TSXV:ARCH TSX:RVX XCNQ:LOBE TSX:MDNA TSX:BCT TSX:MBX TSXV:MIR XCNQ:MDMA XCNQ:DTC VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges Q8M:Germany TTI:Canada

Address 4 King Street West, Suite 401, Toronto, ON, CAN, M5H 1B6

Website https://www.thiogenesis.com

Thiogenesis Therapeutics Corp is a clinical-stage biotechnology company developing TTI-0102, a novel controlled-release cysteamine prodrug designed to improve tolerability and dosing relative to existing therapies. The Company is focused on TTI-0102 in nephropathic cystinosis, where it is in late-stage development, and is also conducting research and clinical development activities for primary mitochondrial diseases, including Leigh syndrome spectrum disorders.

12GF Score

Get the complete analysis for TTIPF

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42

Price

View TTIPF Analysis

See Preferred Dividends data for all stocks →